Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.50    2.00 (1.86%)
Bid:
105.50
Ask:
106.50
Spread: 1.00 (0.948%)
Market Cap: £107.91m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

AGM Trading Update

19 May 2016 07:00

RNS Number : 6543Y
Eurocell plc
19 May 2016
 

19th May 2016

 

Eurocell plc

AGM Trading Update and Director Appointment

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network, today provides a trading update for the first 20 weeks of the financial year to 13th May 2016.

Eurocell has had a positive start to the year with Group revenues up 16.3% to £69.8 million. Both the Profiles and the Building Plastics divisions delivered improved revenues on last year, with like for like sales in the branch network ahead by 11.8%, although in a very competitive market. There were 7 new branches opened during the period and the Company is on track to deliver 15 new sites in the current year as a whole. Both of the recent acquisitions, S & S Plastics and Vista Panels are delivering to expectations.

The UK RMI market conditions remain stable, and benefited from relatively mild weather in January and February. We have seen some movement in resin prices through ethylene increases, this has had limited impact to date.

We are also pleased to announce the appointment of Michael Scott as Chief Financial Officer on 1st September 2016. Michael is currently Head of Corporate Finance at Drax Group plc. He has been with Drax since 2005, having previously held the positions of Head of Investor Relations and Group Financial Controller. Michael also served as Interim Group Finance Director between May and December 2015. Prior to joining Drax, he worked for MT International and Arthur Andersen, where he qualified as a Chartered Accountant.

The half year results will be announced on 23 August 2016.

 

Bob Lawson, Chairman of Eurocell, commented:

"Eurocell has had a positive start to the year. We are delighted with today's appointment of Michael as CFO. He will bring considerable relevant experience particularly given his recent finance and IR roles at Drax. Alongside Mark, who is already making a positive impact as CEO, we have the right management team to further develop Eurocell from the strong platform they inherit. Overall, the business is positioned well and I am confident about our prospects for the future."

 

There are no further disclosures to be made on the appointment of Michael Scott pursuant to 9.6.13 of the Listing Rules

 

Further Enquiries:

Ben Foster, Camilla Cunningham 020 3603 5221

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAPMFTMBMBBBF
Date   Source Headline
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSYear End Trading Update
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:30 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSHolding(s) in Company
16th Oct 20234:30 pmRNSDirector/PDMR Shareholding
13th Oct 20234:30 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSInvestor Presentation
21st Sep 20234:30 pmRNSDirector/PDMR Shareholding
7th Sep 20236:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Results
4th Sep 20237:00 amRNSBlock listing Interim Review
9th Aug 20234:30 pmRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading Update - In Line with Expectations
17th Jul 20237:00 amRNSHolding(s) in Company
18th May 20237:00 amRNSHolding(s) in Company
16th May 20234:00 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHolding(s) in Company
15th May 20235:00 pmRNSChanges to Board Committee Memberships
12th May 20237:00 amRNSTrading Update and Board Changes
11th May 20234:30 pmRNSResult of AGM
10th May 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSInvestor Presentation
17th Mar 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.